期刊文献+

腹膜透析性腹膜炎的病原菌分布与耐药分析 被引量:6

原文传递
导出
摘要 血液净化技术是目前治疗终末期肾病的常用方法,其中的腹膜透析能较好地保护残肾功能。但腹膜透析较高发的并发症——腹膜透析相关性腹膜炎(dialysis-related infectious peritonitis, PDAP)是导致腹膜透析失败的最主要原因,也是导致患者死亡的最主要危险因素。据统计,腹膜透析患者因感染住院的比例高于血液透析患者。同时,由于抗生素的广泛使用,也易引起腹膜透析患者病原菌谱及耐药性的变化。
出处 《中华临床实验室管理电子杂志》 2016年第1期57-59,共3页 Chinese Journal of Clinical Laboratory Management(Electronic Edition)
  • 相关文献

参考文献8

  • 1方小敏,方舒,胡玉生,曾涛.腹膜透析相关性腹膜炎患者易感病原菌及耐药性分析[J].临床合理用药杂志,2015,8(26):25-26. 被引量:7
  • 2Lafrance JP, Rahme E, Iqbal S, et al. Association of dialysis modality with risk for infection- related hospitalization: a propensity score-matched cohort analysis[J]. Clin J Am Soc Nephrol, 2012, 7(10): 1598-1605.
  • 3吴晶晶,刘佳,张莉,王珏,邢昌赢.腹膜透析相关性腹膜炎致病菌及耐药性分析[J].中华医院感染学杂志,2011,21(16):3521-3523. 被引量:22
  • 4Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update[J]. Perit Dial Int, 2010, 30(4):393-423.
  • 5Huang ST, Chuang YW, Cheng CW, et al. Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis [J]. Clin Nephrol, 2011, 75 (5) :416-425.
  • 6Kofteridis DP, Valachis A, Perakis K, et al. Peritoneal dialysis as-sociated peril: clinical features and predictors of outcome [J]. Int J Infect Dis, 2010,14(6) : 489-493.
  • 7Lui SL, Cheng SW, Ng F, et al. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis:effect on residual renal function [J]. Kidney Int, 2005,68(5):2375- 2380.
  • 8贾征夫.腹膜透析液分离病原菌种类分布及耐药性分析[J].中华医院感染学杂志,2011,21(1):180-182. 被引量:6

二级参考文献16

  • 1余方友,李美兰,林晓梅,周铁丽,陈增强,王薇薇,戴美杰,陈坚,刘桂胜.耐甲氧西林金黄色葡萄球菌的SCCmec基因型及耐药谱研究[J].中华微生物学和免疫学杂志,2006,26(6):543-543. 被引量:11
  • 2郭群英,陈林,阳晓,杨念生,冯敏,姜宗培,毛海萍,陈崴,余学清.腹膜透析相关感染性腹膜炎致病菌及菌谱变化——单个腹膜透析中心15年回顾分析[J].中华肾脏病杂志,2006,22(12):719-724. 被引量:64
  • 3Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations:2010 update[J]. Petit Dial Int, 2010,30(4) : 393-423.
  • 4Yoon SH,Choi NW,Yun SR. Detecting bacterial growth in con- tiruous ambulatory peritoneal dialysis effluent using two culture methods[J]. Korean J Intern Med,2010,25(1) :82-85.
  • 5Shigidi MM, Fituri OM, Chandy SK, et al. Microbial spec- trum and outcome of peritoneal dialysis related peritonitis in Qatar[J]. Saudi J Kidney Dis Transpl, 2010,21 (1) : 168-173.
  • 6Strippoli GF,Tong A,Johnson D,et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients [J]. Cochrane Database Syst Rev, 2004,18 (4) :CD004679.
  • 7Lui SL, Cheng SW, Ng SY, et al. Cefazolin plus netilmicin versus cefazolin plus eeftazidime for treating CAPD peritonitis: effect on residual renal function[J]. Kidney Int,2005,68(5) :2375-2380.
  • 8Lafrance JP, Rahme E, Iqbal S, et al. Association of dialysis modality with risk for infection-related hospitalization:a propensity score-matched cohort analysis [ J ]. Clin J Am Soc Nephrol,2012,7 (10) :1598 - 1605.
  • 9Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations :2010 update [ J ]. Petit Dial Int, 2010,30 (4) : 393 - 423.
  • 10Basturk T, Koc Y, Unsal A, et al. Fungal peritonitis in peritoneal dialy- sis:a 10 year retrospective analysis in a single center [J ]. Eur Rev Med Pharmacol Sci ,2012,16 ( 12 ), 1696 - 1700.

共引文献28

同被引文献27

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部